Fabry Disease
📧 Sign up to get email alerts when something new happens for Fabry Disease.
Sign up freeTop drugs studied for this disease
-
EMA guidance · 2010-07-06European Medicines Agency updates treatment recommendations because of continued Fabrazyme shortage
EMA updates treatment recommendations due to ongoing Fabrazyme shortage, adjusting guidance on management for patients requiring enzyme repl…
-
EMA guidance · 2010-04-23European Medicines Agency gives new temporary treatment recommendations for Fabrazyme
EMA provides new temporary treatment recommendations for Fabrazyme, outlining updated dosing or usage guidance while further evaluations con…
-
EMA guidance · 2009-09-25Supply shortage of Fabrazyme – updated treatment recommendations required for adult male patients
EMA updates treatment recommendations for Fabrazyme due to supply shortage, focusing on adult male patients.
-
EMA guidance · 2009-06-25Supply shortages of Cerezyme and Fabrazyme - priority access for patients most in need of treatment recommended
EMA recommends priority access to Cerezyme and Fabrazyme during supply shortages to ensure treatment for patients most in need.